EdgarLookup

FARMHOUSE, INC. /NV — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that FARMHOUSE, INC. /NV filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-63124.6%
Profit Margin
Net income ÷ revenue
-688%
Return on Assets
Net income ÷ assets
-1.02x
Debt-to-Equity
Total liabilities ÷ equity
-85%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $623 Apr 17, 2026
FY2025 Dec 31, 2024 $4.2K Apr 17, 2026
FY2024 Dec 31, 2023 $15.2K Jun 23, 2025
FY2023 Dec 31, 2022 $10.3K Jul 11, 2024
FY2022 Dec 31, 2021 $12.2K Apr 20, 2023
FY2021 Dec 31, 2020 $16.7K Apr 22, 2022
FY2020 Dec 31, 2019 $41.3K Apr 30, 2021

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $498 Apr 17, 2026
FY2025 Dec 31, 2024 $2.3K Apr 17, 2026
FY2024 Dec 31, 2023 $8.3K Jun 23, 2025
FY2023 Dec 31, 2022 $6.5K Jul 11, 2024
FY2022 Dec 31, 2021 $4.2K Apr 20, 2023
FY2021 Dec 31, 2020 $16.7K Apr 22, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($393.3K) Apr 17, 2026
FY2025 Dec 31, 2024 ($464.3K) Apr 17, 2026
FY2024 Dec 31, 2023 ($560.8K) Jun 23, 2025
FY2023 Dec 31, 2022 ($442.8K) Jul 11, 2024
FY2022 Dec 31, 2021 ($975.6K) Apr 20, 2023
FY2021 Dec 31, 2020 ($1.05M) Apr 22, 2022
FY2020 Dec 31, 2019 ($563.1K) Apr 30, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($410.4K) Apr 17, 2026
FY2025 Dec 31, 2024 ($408.4K) Apr 17, 2026
FY2024 Dec 31, 2023 ($509.5K) Jun 23, 2025
FY2023 Dec 31, 2022 ($779.6K) Jul 11, 2024
FY2022 Dec 31, 2021 ($970.4K) Apr 20, 2023
FY2021 Dec 31, 2020 ($1.01M) Apr 22, 2022
FY2020 Dec 31, 2019 ($550.9K) Apr 30, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($179.0K) Apr 17, 2026
FY2025 Dec 31, 2024 ($106.4K) Apr 17, 2026
FY2024 Dec 31, 2023 ($83.5K) Jun 23, 2025
FY2023 Dec 31, 2022 ($270.9K) Jul 11, 2024
FY2022 Dec 31, 2021 ($210.2K) Apr 20, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $57.2K Apr 17, 2026
FY2025 Dec 31, 2024 $30.8K Apr 17, 2026
FY2024 Dec 31, 2023 $8.2K Jun 23, 2025
FY2023 Dec 31, 2022 $65.9K Jul 11, 2024
FY2022 Dec 31, 2021 $7.9K Apr 20, 2023
FY2021 Dec 31, 2020 $5.2K Apr 22, 2022
FY2020 Dec 31, 2019 $348.1K Apr 30, 2021

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.73M Apr 17, 2026
FY2025 Dec 31, 2024 $2.37M Apr 17, 2026
FY2024 Dec 31, 2023 $1.99M Jun 23, 2025
FY2023 Dec 31, 2022 $1.65M Jul 11, 2024

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($2.67M) Apr 17, 2026
FY2025 Dec 31, 2024 ($2.34M) Apr 17, 2026
FY2025 Dec 31, 2023 ($1.98M) Apr 17, 2026
FY2024 Dec 31, 2022 ($1.58M) Jun 23, 2025
FY2023 Dec 31, 2021 ($1.57M) Jul 11, 2024
FY2022 Dec 31, 2020 ($1.14M) Apr 20, 2023
FY2021 Dec 31, 2019 ($439.8K) Apr 22, 2022
FY2020 Dec 31, 2018 ($539.0K) Apr 30, 2021

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($7.16M) Apr 17, 2026
FY2025 Dec 31, 2024 ($6.77M) Apr 17, 2026
FY2024 Dec 31, 2023 ($6.31M) Jun 23, 2025
FY2023 Dec 31, 2022 ($5.74M) Jul 11, 2024
FY2022 Dec 31, 2021 ($5.30M) Apr 20, 2023
FY2021 Dec 31, 2020 ($4.33M) Apr 22, 2022
FY2020 Dec 31, 2019 ($3.28M) Apr 30, 2021

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $14.2K Apr 17, 2026
FY2025 Dec 31, 2024 $413 Apr 17, 2026
FY2024 Dec 31, 2023 $0 Jun 23, 2025
FY2023 Dec 31, 2022 $62.1K Jul 11, 2024
FY2022 Dec 31, 2021 $3.8K Apr 20, 2023
FY2021 Dec 31, 2020 $3.9K Apr 22, 2022
FY2021 Dec 31, 2019 $7.3K Apr 22, 2022
FY2020 Dec 31, 2018 $3.3K Apr 30, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 18.93M Apr 17, 2026
FY2025 Dec 31, 2024 17.93M Apr 17, 2026
FY2024 Dec 31, 2023 17.33M Jun 23, 2025
FY2023 Dec 31, 2022 17.08M Jul 11, 2024
FY2022 Dec 31, 2021 15.69M Apr 20, 2023
FY2021 Dec 31, 2020 14.86M Apr 22, 2022
FY2020 Dec 31, 2019 14.50M Apr 30, 2021